IVF denied as not FDA-approved for this use by Cigna?

Cigna's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Your IVF as Not FDA-Approved

IVF is a medical procedure, not a drug or device requiring FDA approval in the traditional sense. When Cigna issues a "not FDA-approved" denial for IVF, it is almost always a misapplication of a denial code designed for drugs or medical devices to a procedural service. In some cases, it may target a specific laboratory technique or add-on technology used during the IVF process rather than IVF itself. Either way, this denial type is frequently overturned because it rests on an incorrect regulatory characterization.

## Why This Denial Is Appealable

The FDA does not issue approvals for IVF as a procedure in the same way it approves drugs. Applying an FDA-approval standard to a procedural service is a category error. Your appeal should document that IVF is a well-established standard-of-care procedure recognized by major reproductive medicine organizations, that no FDA "approval" is required or exists for this type of service, and that Cigna's denial criteria are being applied to the wrong regulatory category. If the denial targets a specific device or add-on used during the cycle, your physician can provide the appropriate regulatory clearance documentation for that component.

## Federal Appeal Framework

• Internal appeal: File under ERISA §503 or applicable state law within the deadline on your denial notice. Request the specific clinical policy bulletin or coverage guideline Cigna used, and ask Cigna to identify precisely what FDA approval it believes is required and what documentation would satisfy that standard.
• External review: Under ACA §2719, escalate to an independent external review organization if the internal appeal is denied. File within four months of the final internal denial. IROs are well-positioned to identify and correct category errors in denial rationale.
• Expedited review: If fertility timeline considerations make delay medically harmful, request expedited review with physician certification.

## Documentation to Gather

• Procedure clarification letter: A letter from your reproductive endocrinologist explaining that IVF is a standard medical procedure not subject to FDA drug or device approval, and confirming it is the recognized standard of care for your diagnosis.
• Diagnosis and medical records: Full clinical documentation establishing the medical indication for IVF.
• Regulatory documentation (if add-on is the target): If a specific laboratory technology or device was denied, obtain the FDA 510(k) clearance or other applicable regulatory documentation for that component from the manufacturer.
• Cigna policy request: Obtain the specific coverage policy or clinical policy bulletin applied; identify the exact language invoking the FDA-approval standard.
• Prior authorization records: If any prior components of the cycle were authorized, include those as evidence of Cigna's own prior recognition of the service.

## Criteria-Mapping Structure

Obtain Cigna's clinical policy bulletin. Identify the specific FDA-approval requirement cited. In your appeal, address that specific requirement: document the applicable regulatory classification for each component of IVF, confirm whether FDA clearance exists and what form it takes, and explain why the standard being applied is categorically inapplicable to this type of service. A concise, factual rebuttal addressing Cigna's exact language is the most effective structure.